Top

Published in:

01-01-2016 | Annual Review Issue

Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks

Authors: S. Schmitt, K. Kynast, P. Schirmacher, E. Herpel

Published in: Virchows Archiv | Issue 1/2016

Abstract

Availability of high-quality human tissue samples and access to associated histopathological and clinical data is essential for basic and translational biomedical research, especially in areas of personalized medicine, drug, and biomarker development and mechanistically oriented biomedical research projects. Therefore, it is pivotal to establish and maintain quality-assured tissue biobanks that provide high-quality biomaterial to research thereby increasing the impact and reliability of scientific results. Quality concerns do not only address the biomaterial specimen itself but include all biobanking-related procedures. Tissue biobanks thus face essential challenges that encompass the implementation of adequate structural components, documentation of tissue sample collection and storage (procedures), as well as data and project management and IT. An integral and indispensable component of tissue biobanks is expert-driven evaluation (entry and exit controls) of tissue specimen to guarantee provision of high-quality assured biomaterials.

Shickle D, Griffin M, El-Arifi K (2010) Inter- and intra-biobank networks: classification of biobanks. Pathobiology : journal of immunopathology, molecular and cellular biology 77(4):181–190. doi:10.1159/000292651 CrossRef

Hallmans G, Vaught JB (2011) Best practices for establishing a biobank. Methods Mol Biol 675:241–260. doi:10.1007/978-1-59745-423-0_13 CrossRefPubMed

Goebel JW, Pickardt T, Bedau M, Fuchs M, Lenk C, Paster I, Spranger TM, Stockter U, Bauer U, Cooper DN, Krawczak M (2010) Legal and ethical consequences of international biobanking from a national perspective: the German BMB-EUCoop project. Eur J Hum Genet 18(5):522–525. doi:10.1038/ejhg.2009.214 PubMedCentralCrossRefPubMed

Cordell S (2011) The biobank as an ethical subject. Health Care Anal : HCA : J Health Philo Policy 19(3):282–294. doi:10.1007/s10728-011-0180-1 CrossRef

Vaught J, Lockhart NC (2012) The evolution of biobanking best practices. Clin Chim Acta 413(19–20):1569–1575. doi:10.1016/j.cca.2012.04.030 PubMedCentralCrossRefPubMed

Hewitt RE (2011) Biobanking: the foundation of personalized medicine. Curr Opin Oncol 23(1):112–119. doi:10.1097/CCO.0b013e32834161b8 CrossRefPubMed

Lehmann S, Guadagni F, Moore H, Ashton G, Barnes M, Benson E, Clements J, Koppandi I, Coppola D, Demiroglu SY, DeSouza Y, De Wilde A, Duker J, Eliason J, Glazer B, Harding K, Jeon JP, Kessler J, Kokkat T, Nanni U, Shea K, Skubitz A, Somiari S, Tybring G, Gunter E, Betsou International Society For B, Environmental Repositories Isber Working Group On Biospecimen Science F (2012) Standard preanalytical coding for biospecimens: review and implementation of the sample PREanalytical code (SPREC). Biopreserv Biobanking 10(4):366–374. doi:10.1089/bio.2012.0012 CrossRef

Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, DeSouza Y, Eliason J, Glazer B, Guadagni F, Harding K, Horsfall DJ, Kleeberger C, Nanni U, Prasad A, Shea K, Skubitz A, Somiari S, Gunter E, International Society for B, Environmental Repositories Working Group on Biospecimen S (2010) Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomark Prev 19(4):1004–1011. doi:10.1158/1055-9965.EPI-09-1268, A Publication of The American Association for Cancer Research, Cosponsored by the American Society of Preventive OncologyCrossRef

Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield EA, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J (2011) Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 119(2):92–101. doi:10.1002/cncy.20147 CrossRefPubMed

10.

Steg A, Wang W, Blanquicett C, Grunda JM, Eltoum IA, Wang K, Buchsbaum DJ, Vickers SM, Russo S, Diasio RB, Frost AR, LoBuglio AF, Grizzle WE, Johnson MR (2006) Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn: JMD 8(1):76–83. doi:10.2353/jmoldx.2006.040402 PubMedCentralCrossRefPubMed

11.

Grizzle WE, Bell WC, Sexton KC (2010) Issues in collecting, processing and storing human tissues and associated information to support biomedical research. Cancer Biomark 9(1–6):531–549. doi:10.3233/CBM-2011-0183, Section A of Disease markersPubMedCentralPubMed

12.

Grizzle WE, Sexton KC, Bell WC (2008) Quality assurance in tissue resources supporting biomedical research. Cell Preserv Technol 6(2):113–118. doi:10.1089/cpt.2008.9993 PubMedCentralCrossRefPubMed

13.

Simeon-Dubach D, Burt AD, Hall PA (2012) Quality really matters: the need to improve specimen quality in biomedical research. J Pathol 228(4):431–433. doi:10.1002/path.4117

14.

Herpel E, Koleganova N, Schreiber B, Walter B, Kalle CV, Schirmacher P (2012) Structural requirements of research tissue banks derived from standardized project surveillance. Virchows Arch 461(1):79–86. doi:10.1007/s00428-012-1258-3, An International Journal of PathologyCrossRefPubMed

15.

Herpel E, Rocken C, Manke H, Schirmacher P, Flechtenmacher C (2010) Quality management and accreditation of research tissue banks: experience of the National Center for Tumor Diseases (NCT) Heidelberg. Virchows Arch 457(6):741–747. doi:10.1007/s00428-010-0998-1, An International Journal of PathologyCrossRefPubMed

16.

Herpel E, Roecken C, Manke H, Schirmacher P, Flechtenmacher C (2011) Letter to the editor—reply to comments of Carter et al. Virchows Arch 458(2):249–250. doi:10.1007/s00428-010-1029-y CrossRef

17.

ISO (2015) http://www.iso.org/iso/home/standards_development/list_of_iso_technical_committees/iso_technical_committee.htm?commid=4514241

18.

Bell WC, Sexton KC, Grizzle WE (2009) How to efficiently obtain human tissues to support specific biomedical research projects. Cancer Epidemiol Biomark Prev 18(6):1676–1679. doi:10.1158/1055-9965.EPI-08-0820, A Publication of The American Association for Cancer Research, Cosponsored by the American Society of Preventive OncologyCrossRef

19.

Simeon-Dubach D, Perren A (2011) Better provenance for biobank samples. Nature 475(7357):454–455. doi:10.1038/475454d CrossRefPubMed

20.

McDonald SA, Watson MA, Rossi J, Becker CM, Jaques DP, Pfeifer JD (2011) A new paradigm for biospecimen banking in the personalized medicine era. Am J Clin Pathol 136(5):679–684. doi:10.1309/AJCP7DWCQ1SWJTWU PubMedCentralCrossRefPubMed

21.

Baker M (2012) Biorepositories: building better biobanks. Nature 486(7401):141–146. doi:10.1038/486141a CrossRefPubMed

22.

Bevilacqua G, Bosman F, Dassesse T, Hofler H, Janin A, Langer R, Larsimont D, Morente MM, Riegman P, Schirmacher P, Stanta G, Zatloukal K, Caboux E, Hainaut P (2010) The role of the pathologist in tissue banking: European Consensus Expert Group report. Virchows Arch 456(4):449–454. doi:10.1007/s00428-010-0887-7, An International Journal of PathologyPubMedCentralCrossRefPubMed

23.

Herpel E, Hummel M (2013) Research biobanks—development and structure. Dtsch Med Wochenschr 138(20):1069–1072. doi:10.1055/s-0033-1343143 CrossRefPubMed

24.

Watson P (2002) The importance of tumor banking: bridging no-mans-land in cancer research. Expert Rev Anticancer Ther 2(1):1–3. doi:10.1586/14737140.2.1.1 CrossRefPubMed

25.

Henry NL, Hayes DF (2012) Cancer biomarkers. Mol Oncol 6(2):140–146. doi:10.1016/j.molonc.2012.01.010 CrossRefPubMed

26.

Simeon-Dubach D, Watson P (2014) Biobanking 3.0: evidence based and customer focused biobanking. Clin Biochem 47(4–5):300–308. doi:10.1016/j.clinbiochem.2013.12.018 CrossRefPubMed

27.

Watson PH, Nussbeck SY, Carter C, O'Donoghue S, Cheah S, Matzke LAM, Barnes RO, Bartlett J, Carpenter J, Grizzle WE, Johnston RN, Mes-Masson A-M, Murphy L, Sexton K, Shepherd L, Simeon-Dubach D, Zeps N, Schacter B (2014) A framework for biobank sustainability. Biopreserv Biobanking 12(1):60–68. doi:10.1089/bio.2013.0064 CrossRef

28.

Cambon-Thomsen A (2003) Assessing the impact of biobanks. Nat Genet 34(1):25–26. doi:10.1038/ng0503-25b CrossRefPubMed

29.

Hofman V, Ilie M, Long E, Washetine K, Chabannon C, Figarella-Branger D, Clement B, Mabile L, Cambon-Thomsen A, Boucher P, Dagher G, Hewitt R, Parodi B, Hofman P (2013) Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output. Biopreserv Biobanking 11(4):235–244. doi:10.1089/bio.2013.0015 CrossRef

Title: Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks
Authors: S. Schmitt
K. Kynast
P. Schirmacher
E. Herpel
Publication date: 01-01-2016
Publisher: Springer Berlin Heidelberg
Published in: Virchows Archiv / Issue 1/2016
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-015-1825-5

At a glance: The STEP trials

Springer Medicine

Challenges for quality management in implementation, maintenance, and sustainability of research tissue biobanks

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Quality assurance in clinical trials—the role of pathology

Endorsing good quality assurance practices in molecular pathology: risks and recommendations for diagnostic laboratories and external quality assessment providers

Communication skills in diagnostic pathology

Proficiency testing in immunohistochemistry—experiences from Nordic Immunohistochemical Quality Control (NordiQC)

The medical autopsy as quality assurance tool in clinical medicine: dreams and realities

Ensuring quality in postgraduate medical education: competency testing is the key